Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study (vol 13, 152, 2023)
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | |
dc.contributor.author | MARTIN, Thomas | |
dc.contributor.author | DIMOPOULOS, Meletios-Athanasios | |
dc.contributor.author | MIKHAEL, Joseph | |
dc.contributor.author | YONG, Kwee | |
dc.contributor.author | CAPRA, Marcelo | |
dc.contributor.author | FACON, Thierry | |
dc.contributor.author | HAJEK, Roman | |
dc.contributor.author | SPICKA, Ivan | |
dc.contributor.author | BAKER, Ross | |
dc.contributor.author | KIM, Kihyun | |
dc.contributor.author | MARTINEZ, Gracia | |
dc.contributor.author | MIN, Chang-Ki | |
dc.contributor.author | POUR, Ludek | |
dc.contributor.author | LELEU, Xavier | |
dc.contributor.author | ORIOL, Albert | |
dc.contributor.author | KOH, Youngil | |
dc.contributor.author | SUZUKI, Kenshi | |
dc.contributor.author | CASCA, France | |
dc.contributor.author | MACE, Sandrine | |
dc.contributor.author | RISSE, Marie-Laure | |
dc.contributor.author | MOREAU, Philippe | |
dc.date.accessioned | 2024-04-05T19:39:33Z | |
dc.date.available | 2024-04-05T19:39:33Z | |
dc.date.issued | 2023 | |
dc.description.index | MEDLINE | |
dc.description.index | PubMed | |
dc.description.index | Scopus | |
dc.description.index | Dimensions | |
dc.description.index | WoS | |
dc.identifier.citation | BLOOD CANCER JOURNAL, v.13, n.1, article ID 152, 1p, 2023 | |
dc.identifier.doi | 10.1038/s41408-023-00923-6 | |
dc.identifier.issn | 2044-5385 | |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/59204 | |
dc.language.iso | eng | |
dc.publisher | SPRINGERNATURE | eng |
dc.relation.ispartof | Blood Cancer Journal | |
dc.rights | openAccess | eng |
dc.rights.holder | Copyright SPRINGERNATURE | eng |
dc.subject.wos | Oncology | eng |
dc.subject.wos | Hematology | eng |
dc.title | Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study (vol 13, 152, 2023) | eng |
dc.type | article | eng |
dc.type.category | correction | eng |
dc.type.version | publishedVersion | eng |
dspace.entity.type | Publication | |
hcfmusp.citation.scopus | 0 | |
hcfmusp.contributor.author-fmusphc | GRACIA APARECIDA MARTINEZ | |
hcfmusp.description.articlenumber | 152 | |
hcfmusp.description.issue | 1 | |
hcfmusp.description.volume | 13 | |
hcfmusp.origem | WOS | |
hcfmusp.origem.dimensions | pub.1164401319 | |
hcfmusp.origem.pubmed | 37752114 | |
hcfmusp.origem.scopus | 2-s2.0-85172403466 | |
hcfmusp.origem.wos | WOS:001074479900002 | |
hcfmusp.publisher.city | LONDON | eng |
hcfmusp.publisher.country | ENGLAND | eng |
hcfmusp.scopus.lastupdate | 2024-05-17 | |
relation.isAuthorOfPublication | c94bd478-b7c9-45f5-95f3-1afb6b5eb3c5 | |
relation.isAuthorOfPublication.latestForDiscovery | c94bd478-b7c9-45f5-95f3-1afb6b5eb3c5 |